Abstract OT3-07-01: Real-World Data on First-line Treatment of HR-positive, HER2-negative, Metastatic Breast Cancer in Brazil (BRAVE Study/LACOG 0221)

01/03/2023

Gustavo Werutsky; Tomás Reinert; Daniela D. Rosa; Romualdo Barroso-Sousa; Heloísa Resende; Poliana A. Signorini; Juliana G. Martins Fagundes; Jose Marcio B. Figueiredo; Eduardo Cronemberger; Aline C. Vieira; Jorge Henrique Santos Leal; Luiza Nardin Weis; Ludmila Thommen; Rafaela G. Jesus; Gustavo Gössling; José Bines

DOI: 10.1158/1538-7445.SABCS22-OT3-07-01

Full link: https://aacrjournals.org/cancerres/article/83/5_Supplement/OT3-07-01/718039/Abstract-OT3-07-01-Real-World-Data-on-First-line

Abstract OT3-07-01: Real-World Data on First-line Treatment of HR-positive, HER2-negative, Metastatic Breast Cancer in Brazil (BRAVE Study/LACOG 0221)

Send us a message

Cura Project

Abstract OT3-07-01: Real-World Data on First-line Treatment of HR-positive, HER2-negative, Metastatic Breast Cancer in Brazil (BRAVE Study/LACOG 0221)

Related Posts

1506TiP A single-arm, phase II study of amivantamab (AMI), lazertinib (L) and pemetrexed (P) for first-line treatment of recurrent/metastatic non-small cell lung cancers (NSCLCS) with epidermal growth factor receptor mutations in Exons 19 or 21 (EGFR 19/21): AMIGO 1 (LACOG0821)

Real-world evidence for oncological outcomes after radiotherapy or surgery for T1a-T1b glottic squamous cell carcinoma: A population-based cohort study

Clinical validation and diagnostic accuracy of 99mTc-EDDA/HYNIC-TOC compared to 111In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 study

A Meta-analysis of the Efficacy and Safety of Stereotactic Arrhythmia Radioablation (STAR) in Patients with Refractory Ventricular Tachycardia